PAT-SM6 is manufactured in the USA.
Yes, getting approval to do trials in Germany is not easy...controlled by the Paul Ehrlich Institute. No reason why PAB can't get approval though as they have successfully navigated the approval process before and executed a successful clinical trial in Germany. Question is though...do they have the right people to get this done and if they are making progress, then why are we not hearing anything about it?????
What's the root cause of PAB's poor SP performance?, page-13
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 5382389 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2352699 | 1 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable